visceral adipose tissue is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
=== N05CM Other hypnotics and sedatives === N05CM01 Methaqualone N05CM02 Clomethiazole N05CM03 Bromisoval N05CM04 Carbromal N05CM05 Scopolamine N05CM06 Propiomazine N05CM07 Triclofos N05CM08 Ethchlorvynol N05CM10 Hexapropymate N05CM11 Bromides N05CM12 Apronal N05CM13 Valnoctamide N05CM15 Methylpentynol N05CM16 Niaprazine N05CM18 Dexmedetomidine N05CM20 Diphenhydramine N05CM22 Promethazine N05CM25 Magnesium aspartate hydrobromide N05CM26 Magnesium glutamate hydrobromide N05CM27 Doxylamine
He narrated the Fulldome production Astronaut (2006), created for the National Space Centre. Around the same time, he also narrated the STV show JetSet (also 2006), a six-part series following the lives of trainee pilots and navigators at RAF Lossiemouth as they undergo a gruelling six-month course learning to fly the Tornado GR4, the RAF's primary attack aircraft. McGregor starred opposite Colin Farrell in the Woody Allen film Cassandra's Dream (2007), and he co-starred with Jim Carrey in I Love You Phillip Morris and appeared in Amelia (both 2009) alongside Hilary Swank. He played "the ghost" – the unnamed main character – in Roman Polanski's political thriller The Ghost Writer (2010). He portrayed Camerlengo Patrick McKenna in Ron Howard's mystery thriller Angels & Demons (also 2009), the film adaptation of Dan Brown's novel of the same name and a sequel to Howard's The Da Vinci Code, co-starring Tom Hanks as Robert Langdon. In 2011, McGregor starred in the British comedy Salmon Fishing in the Yemen directed by Lasse Hallström and co-starring Emily Blunt and Kristin Scott Thomas, for which he received his second Golden Globe Award for Best Actor – Motion Picture Musical or Comedy nomination. That same year, he was awarded with the SIFF Golden Space Needle Award for Outstanding Achievement in Acting at the 2011 Seattle International Film Festival. In 2012, he was a member of the Jury for the Main Competition at the 2012 Cannes Film Festival.
=== Tumblr === There exists a large population of self-identified mentally ill users on Tumblr, where the ability to post more unfiltered content led to individuals arguably sensationalizing and glamorizing mental illnesses and suicide. A thesis on Tumblr poetry explains how "the site serves as both a place of relief for people with mental health disorders, or even just every day growing pains, but it can also act as an enabling source for users who use the site as an echo chamber for their own problematic coping mechanisms, implying a groupthink problem that can exist in this kind of digital space." Tumblr staff attempted to prevent the use of their platform for romanticizing mental illness by changing their policies in 2012 to prohibit content actively promoting or depicting self harm and showing Public Service Announcements instead of results when users search keywords related to self-harm, such as "proana," "thinspo," "thinspiration," "purge," "bulimia," "anorexic," and more.
The white shark has a stocky, torpedo-shaped body with a short, cone-shaped snout. Its long gill slits do not reach around the head. It has a large triangular first dorsal fin, which partly lines up with the pectoral fins, and a tiny second dorsal fin. The tail fin has two lobes of similar size and a single ridge or keel, and the anal fin is tiny. The white shark has a countershaded coloration for camouflage; being dark on top, usually blue-gray or gray-brown, with a white underside. It also has black tips on the underside of the pectoral fins. There is evidence that the species can change pigments, adding dark pigment or melanin to blotches of white over the course of months. The skin is covered in dermal denticles (tooth-like scales), which are proportionally smaller than in other sharks and have a three-to-five-ridged surface, with each ridge having tips that point backwards.
Sources: en.wikipedia.org
Through pilot project funding, multidisciplinary mentorship, educational seminars, career development programs, and collaborative research opportunities, the Center provides early-stage investigators with the resources necessary to establish independent research programs. Junior faculty benefit from access to experienced mentors across multiple disciplines, specialized research cores, and opportunities to participate in multicenter studies and national collaborations. These efforts are closely integrated with the Barshop Institute's NIH-funded Biology of Aging Training Program (T32), creating a comprehensive environment for training predoctoral students, postdoctoral fellows, clinical fellows, and junior faculty in translational geroscience and geriatrics.
1925: British-American astronomer and astrophysicist Cecilia Payne-Gaposchkin established that hydrogen is the most common element in stars, and thus the most abundant element in the universe. 1926: American scientist Katharine Burr Blodgett became the first woman to earn a PhD in physics at the University of Cambridge, under the supervision of Sir Ernest Rutherford. 1927: Japanese biologist and cytologist Kono Yasui became the first Japanese woman to earn a doctorate in science, studying at the Tokyo Imperial University and completing her thesis on "Studies on the structure of lignite, brown coal, and bituminous coal in Japan". 1927: Bohumila Bednářová, the first Czech woman to become professionally involved in astronomy, co-founds the Prague Observatory. 1928: American microbiologist Alice Evans became the first woman elected president of the Society of American Bacteriologists. 1928: Helen Battle became the first woman to earn a PhD in marine biology in Canada. 1928: British biologist Kathleen Carpenter published the first English-language textbook devoted to freshwater ecology: Life in Inland Waters. 1929: American botanist Margaret Clay Ferguson became the first female president of the Botanical Society of America. 1929: Scottish-Nigerian physician Agnes Yewande Savage became the first West African woman to graduate from medical school, obtaining her degree at the University of Edinburgh Medical School.
Dundee becomes the second city in Scotland to introduce a low emission zone. 30 May – Police searching for a father and son missing after hillwalking in Glen Coe confirm they have found two bodies. 31 May – Scotland's UEFA Women's Euro 2025 qualifier match against Israel is delayed after a protestor padlocks himself to the goalposts at Hampden Park. A 24-year-old man is subsequently charged over the incident.
==== Epicardial fat ==== Epicardial adipose tissue (EAT) is a particular form of visceral fat deposited around the heart and found to be a metabolically active organ that generates various bioactive molecules, which might significantly affect cardiac function. Marked component differences have been observed in comparing EAT with subcutaneous fat, suggesting a location-specific impact of stored fatty acids on adipocyte function and metabolism.
== Signs and symptoms == The clinical findings in all three CCDs result from the consequences of decreased levels of creatine in tissues where it is required. In affected individuals with any of the three disorders, there is an almost complete absence of creatine and phosphocreatine in the brain. The two tissues with the highest demands for creatine are the brain and skeletal muscles. Muscular findings usually include weakness and decreased endurance. Other clinical findings include seizures, intellectual disability and developmental delay. Most affected individuals appear normal at birth, with clinical findings becoming apparent during the first year of life, and progressing.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.